GSK PLC Sponsored ADR (NYSE:GSK) Announces Dividend Increase - $0.45 Per Share

Key Points

• GSK raised its quarterly dividend to $0.4518 per share from $0.4515, payable January 7 to shareholders of record on November 13. The annualized dividend is $1.81, representing a 3.7% yield.
• The dividend appears well covered, with a 36.6% payout ratio; analysts expect next year’s earnings to support an estimated 35.4% payout ratio.
• GSK shares opened at $48.71, down 4.4%, while the company’s latest quarterly results exceeded expectations with $1.36 in EPS and $11.14 billion in revenue.

GSK PLC Sponsored ADR (NYSE:GSK - Get Free Report) announced a quarterly dividend on Wednesday, October 28th. Investors of record on Friday, November 13th will be paid a dividend of $0.4518 per share by the pharmaceutical company on Thursday, January 7th. This represents a $1.81 annualized dividend and a dividend yield of 3.7%. The ex-dividend date of this dividend is Friday, November 13th. This is a 0.1% increase from GSK's previous quarterly dividend of $0.4515.

GSK has decreased its dividend payment by an average of 0.1% annually over the last three years. GSK has a payout ratio of 36.6% indicating that its dividend is sufficiently covered by earnings. Research analysts expect GSK to earn $5.00 per share next year, which means the company should continue to be able to cover its $1.77 annual dividend with an expected future payout ratio of 35.4%.

GSK Stock Down 4.4%

Shares of GSK opened at $48.71 on Thursday. The firm has a market cap of $98.52 billion, a P/E ratio of 15.23, a price-to-earnings-growth ratio of 2.28 and a beta of 0.33. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.52 and a current ratio of 0.82. GSK has a 52 week low of $45.50 and a 52 week high of $61.69. The firm's 50-day simple moving average is $49.57 and its 200 day simple moving average is $52.35.

GSK (NYSE:GSK - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The pharmaceutical company reported $1.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.09. GSK had a net margin of 14.56% and a return on equity of 43.23%. The firm had revenue of $11.14 billion during the quarter, compared to the consensus estimate of $11.02 billion. During the same period last year, the business posted $0.47 earnings per share. The business's revenue for the quarter was up 5.3% compared to the same quarter last year. On average, analysts forecast that GSK will post 4.78 earnings per share for the current year.

About GSK

GSK plc, formerly GlaxoSmithKline, is a global biopharmaceutical company headquartered in Brentford, England. The company focuses on researching, developing and commercializing medicines and vaccines designed to prevent and treat infectious diseases, respiratory conditions, immune-related disorders and certain cancers.

Its vaccine portfolio includes products such as Shingrix for shingles, Arexvy for respiratory syncytial virus (RSV) in older adults, and vaccines targeting meningitis, influenza and other infectious diseases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.